EUVIMEDEUVIMED entdecken
Crossref

Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis

Xuting Li, Yi Yuan, Changhong Lian, Dongdong Zhu, Yan Wang, Zhenlei Jia iD

Journal of Biomaterials Applications · 12.08.2026

DOI: 10.1177/08853282261476791 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, online erschienen am 12.08.2026. Verfasst von Xuting Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shangyu People's Hospital of Shaoxing, Shaoxing, China. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Zhejiang Provincial Administration of Traditional Chinese Medicine Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis progression is closely linked to metabolic dysfunction of plaque macrophages, where inducible nitric oxide synthase (iNOS)-mediated pathological nitric oxide (NO) burst is a key driver of inflammation and oxidative stress. This study designed macrophage membrane-camouflaged liposomes (M-AN@Lip) for the co-delivery of nicotinamide mononucleotide (NMN) and L-arginine (L-Arg), aiming to precisely regulate macrophage NO metabolic homeostasis. In vitro experiments demonstrated that M-AN@Lip effectively increased intracellular NO generation while significantly downregulating the expression of the oxidative stress-related enzyme NAD(P)H quinone oxidoreductase 1 (NQO1), suggesting a reprogramming of macrophage NO metabolism from a pathological iNOS-dominated pathway towards a protective one. This metabolic shift was accompanied by clearance of intracellular reactive oxygen species (ROS), enhancement of the endogenous antioxidant enzyme system, and polarization of macrophages towards an anti-inflammatory M2 phenotype. Ultimately, M-AN@Lip significantly inhibited oxidized low-density lipoprotein (ox-LDL) uptake and foam cell formation by downregulating the expression of scavenger receptors (CD36, MSR1, SRB1). This study demonstrates that a biomimetic nano-system can achieve integrated anti-inflammatory, antioxidant, and anti-foam cell forming effects through the synergistic regulation of NO metabolism, offering a promising novel nanotherapeutic strategy for atherosclerosis.

Schlagwörter

Stichwörter der Autor:innen

Atherosclerosisanti-inflammatory and repairmacrophagemetabolic regulationnanodeliveryoxidative stress

Autor:innen und Institutionen

  • Department of Neurology, Shangyu People's Hospital of Shaoxing, Shaoxing, China.
  • School of Medicine, Shaoxing University, Shaoxing, China.
  • Department of Neurosurgery,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

ORCID-Profile: Zhenlei Jia

Förderung

  • Zhejiang Provincial Administration of Traditional Chinese Medicine Science and Technology Project

Zitieren

APA

Li, X., Yuan, Y., Lian, C., Zhu, D., Wang, Y., & Jia, Z. (2026). Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282261476791

Vancouver

Li X, Yuan Y, Lian C, Zhu D, Wang Y, Jia Z. Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282261476791

BibTeX
@article{Li2026,
  author = {Li, Xuting and Yuan, Yi and Lian, Changhong and Zhu, Dongdong and Wang, Yan and Jia, Zhenlei},
  title = {Membrane-camouflaged liposomes Co-delivering L-Arg and NMN for reprogramming macrophage nitric oxide metabolism in atherosclerosis},
  journal = {Journal of Biomaterials Applications},
  year = {2026},
  doi = {10.1177/08853282261476791}
}
Kostenlos starten →